Peginterferon alfa-2a Pegasys - Treatment - Hepatitis C Online

PDF) Cost-effectiveness analysis of treatment with peginterferon-alfa-2a versus peginterferon-alfa-2b for patients with chronic hepatitis C under the public payer perspective in Brazil

Pegasys (Peginterferon alfa-2a): Uses, Dosage, Side Effects, Interactions, Warning

HBsAg loss with HBsAg/anti-HBs seroconversion and non-detectable HCV-RNA in a patient with chronic HBV e-minus/HCV hepatitis treated with two cycles of antiviral therapy – topic of research paper in Clinical medicine. Download

Future Therapies for Hepatitis C - Jean-Michel Pawlotsky, Robert G Gish, 2006

SASLT practice guidelines: Management of hepatitis C virus infection – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.

Peginterferon alfa-2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapy

Roche 00004035009 - McKesson Medical-Surgical

Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa‐2a plus ribavirin - Romero‐Gómez - 2009 - Hepatology - Wiley Online Library

Low-Dose Peginterferon Alfa-2a Is Safe and Produces a Sustained Virologic Response in Patients With Chronic Hepatitis C and End-Stage Renal Disease - Clinical Gastroenterology and Hepatology

The way forward in HCV treatment — finding the right path

IJERPH, Free Full-Text